![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1313, 2010-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Reactions Weekly, Vol. 1, Iss. 1364, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Canada updates safety info regarding venlafaxine overdose
Inpharma, Vol. 1, Iss. 1663, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Australian Therapeutic Goods Administration (TGA) is reviewing the safety of sibutramine
Reactions Weekly, Vol. 1, Iss. 1304, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
ISMP highlights safety concerns for varenicline
Reactions Weekly, Vol. 1, Iss. 1204, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Australian TGA reports incidence of clozapine-induced constipation
Reactions Weekly, Vol. 1, Iss. 1337, 2011-01 ,pp. :